Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

交易中 11-05 14:26:55 EST

0.9792

+0.0062

+0.64%

最高0.9994	最低0.9700	成交量2.09万
今开0.9900	昨收0.9730	日振幅3.02%
总市值363.30万	流通市值363.14万	总股本371.02万
成交额2.04万	换手率0.56%	流通股本370.85万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":0.9792,"timestamp":1730834636429,"preClose":0.973,"halted":0,"volume":20885,"delay":0,"floatShares":3708500,"shares":3710190,"eps":-13.740521,"marketStatus":"交易中","marketStatusCode":2,"change":0.0062,"latestTime":"11-05 14:26:55 EST","open":0.99,"high":0.9994,"low":0.97,"amount":20402.2611861,"amplitude":0.030216,"askPrice":0.9962,"askSize":735,"bidPrice":0.96,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-13.740521,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":0,"adjPreClose":0.973,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":0.973,"latestTime":"08:00 EST","volume":321,"amount":314.58,"timestamp":1730811602863},"postHourTrading":{"tag":"盘后","latestPrice":0.973,"preClose":0.973,"latestTime":"19:59 EST","volume":38,"amount":36.976,"timestamp":1730768342962},"volumeRatio":0.133122,"impliedVol":6.8861,"impliedVolPercentile":0.9868},"requestUrl":"/m/hq/s/BPTH","defaultTab":"news","newsList":[{"id":"2480005370","title":"Bio-Path Holdings, Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480005370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480005370?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:22","pubTimestamp":1730391770,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时22分，Bio-Path Holdings, Inc.股票出现异动，股价急速下跌5.16%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为3.40%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Exicure, Inc.涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为257.25%、235.62%、179.62%，振幅较大的相关个股有Vaccinex, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Gri Bio, Inc.，振幅分别为47.15%、46.15%、45.95%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002250971a39b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002250971a39b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2479788170","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速跳水5.66%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479788170?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295070,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速下跌5.66%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Biovie Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1620.15%、96.94%、13.89%，振幅较大的相关个股有Tharimmune, Inc.、Cormedix Inc.、Dogwood Therapeutics, Inc.，振幅分别为19.21%、8.86%、6.95%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021311095bd8dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021311095bd8dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2477136160","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477136160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477136160?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:27","pubTimestamp":1729621668,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.61%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5525.90%、4986.46%、2140.56%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2476171233","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速下跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476171233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476171233?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:34","pubTimestamp":1729175680,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时34分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.17%。截至发稿，该股报1.10美元/股，成交量3.0784万股，换手率1.21%，振幅4.87%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223440ab6adb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223440ab6adb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2475787684","title":"Bio-Path Holdings, Inc.盘中异动 早盘大幅下挫7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475787684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475787684?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:08","pubTimestamp":1729001312,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时08分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下跌7.07%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Bright Minds Biosciences Inc.、Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为637.06%、286.51%、177.99%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Apollomics Inc C/Wts 01/04/2028 、Gritstone Bio, Inc.，振幅分别为99.20%、79.69%、33.15%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015220833ab6a46e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015220833ab6a46e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2475362083","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475362083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475362083?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912691,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水5.31%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.、Longboard Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Virpax Pharmaceuticals, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为61.70%、40.73%、26.54%，振幅较大的相关个股有Mustang Bio, Inc.、Rani Therapeutics Holdings, Inc.、Inventiva Sa，振幅分别为10.45%、9.90%、7.94%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421313198e3c42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421313198e3c42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2474744811","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474744811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474744811?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:07","pubTimestamp":1728569223,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时07分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.45%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为227.11%、131.15%、104.96%，振幅较大的相关个股有Genenta Science Spa、Briacell Therapeutics Corp C/Wts 24/02/2025、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为25.48%、21.79%、20.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022070398e3bbcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022070398e3bbcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2473947559","title":"Bio-Path Holdings, Inc.股价拉升50.32% 市值涨164.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473947559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473947559?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:30","pubTimestamp":1728394203,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时30分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升50.32%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Bio-Path Holdings, Inc.、Klotho Neurosciences, Inc.、Fractyl Health, Inc.涨幅较大，Virios Therapeutics, Inc.、Aditxt, Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2598.25%、1602.51%、1045.59%，振幅较大的相关个股有Oragenics Inc.、Nanoviricides, Inc.、Ibio, Inc.，振幅分别为12.43%、5.11%、1.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008213004a1df0dec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008213004a1df0dec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2472379728","title":"Bio-Path Holdings, Inc.盘中异动 快速下跌5.48%报0.860美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472379728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472379728?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:04","pubTimestamp":1727791469,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时04分，Bio-Path Holdings, Inc.股票出现波动，股价大幅下挫5.48%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃，换手率分别为593.19%、531.32%、96.65%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Bioatla, Inc.，振幅分别为82.42%、48.90%、34.66%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012204299719db39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012204299719db39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2470080150","title":"Bio-Path Holdings, Inc.盘中异动 早盘大幅下挫5.38%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470080150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470080150?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:51","pubTimestamp":1727448672,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时51分，Bio-Path Holdings, Inc.股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.880美元/股，成交量1.1977万股，换手率0.47%，振幅1.40%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722511398e396e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722511398e396e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2470446031","title":"Bio-Path Holdings, Inc.盘中异动 临近收盘急速拉升6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470446031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470446031?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:33","pubTimestamp":1727206412,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时33分，Bio-Path Holdings, Inc.股票出现波动，股价急速拉升6.03%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Seelos Therapeutics, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4684.51%、203.83%、187.89%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为132.89%、65.30%、60.77%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092503333298e38b77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092503333298e38b77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2468626126","title":"Bio-Path Holdings, Inc.盘中异动 快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468626126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468626126?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:38","pubTimestamp":1726839508,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时38分，Bio-Path Holdings, Inc.股票出现异动，股价快速跳水5.01%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Novabay Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Novabay Pharmaceuticals, Inc.、Galmed Pharmaceuticals Ltd.、Corbus Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1001.04%、378.79%、17.30%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Galmed Pharmaceuticals Ltd.、Zevra Therapeutics, Inc.，振幅分别为50.21%、16.19%、15.71%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202138289719c033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202138289719c033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2461347666","title":"Bio-Path Holdings, Inc.2024财年第二财季实现净利润-1.87百万美元，同比增加55.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461347666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461347666?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:00","pubTimestamp":1724342424,"startTime":"0","endTime":"0","summary":"8月23日，Bio-Path Holdings, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.87百万美元，同比增加55.79%；其中营业收入为0.00美元，每股基本收益为-1.16美元。从资产负债表来看，Bio-Path Holdings, Inc.总负债3.83百万美元，其中短期债务55000.00美元，资产负债比为1.34，流动比率为1.67。机构评级：截至2024年8月23日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为20.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408230000289f4898b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408230000289f4898b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH"],"gpt_icon":0},{"id":"2461493874","title":"BUZZ--美国股票走势-皮博迪能源公司、雪花公司、托尔兄弟公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461493874","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461493874?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:14","pubTimestamp":1724264082,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月21日 - 标普500指数和纳斯达克指数周三走高，原因是美国截至2024年3月底的就业数据大幅向下修正，表明劳动力市场放缓，支撑了美联储下月降息的希望。美东时间13:36，道琼斯工业平均指数  上涨0.05%，报40,856.99点。标普500指数  上涨0.25%，报5611.22点；纳斯达克综合指数  上涨0.27%，报17864.627点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","GLW","SNOW","NQmain","NNOX","QLD","PRCT",".DJI","SQQQ","BK4554","WWD","TJX","CRC","CEIX","PAGS","PSQ","H","DOG","NEM","LU0109392836.USD","MNQmain","AADI","F","PX","TQQQ","M","KEYS","BTU","AXP","DDM","DJX","SDOW","BPTH","TOL","TXN",".IXIC","BK4533","WKHS","BUZZ","COTY","TWFG","ARCH","UDOW","DXD","ADI"],"gpt_icon":1},{"id":"2461891826","title":"BUZZ--美国股票走势-模拟器件、TJX、德州仪器","url":"https://stock-news.laohu8.com/highlight/detail?id=2461891826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461891826?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:25","pubTimestamp":1724246707,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月21日 - 华尔街主要股指周三将高开，因为投资者在等待美国最新的就业数据和美联储7月份政策会议纪要的公布。.美东时间9:06，道指电子盘  上涨0.17%，报41,018点。标普500指数小型股  上涨0.19%，报5630.5点；纳斯达克100指数小型股  上涨0.19%，报19846.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KEYS","LU1674673428.USD","M","LU1066053197.SGD","BK4141","LU0312595415.SGD","LU2023250504.SGD","LU2458330243.SGD","LU2458330169.SGD","LU1244550221.USD","LU0310800965.SGD","LU2237443978.SGD","F","WWD","BUZZ","TJX","LU0011850046.USD","AXP","LU1674673691.USD","LU0557290698.USD","IE00B5949003.HKD","LU0211328371.USD","NNOX","PX","BK4196","BK4561","BPTH","SG9999003800.SGD","COTY","CEIX","WKHS","ADI","ARCH","SDIG","GLW","LU2237443549.SGD","LU2552382132.HKD","LU2237443622.USD","LU2552382058.USD","PRCT","LU2552382215.SGD","AADI","LU1803068979.SGD","TXN","LU1003077747.HKD","BK4587","BK4585","IE0004445015.USD"],"gpt_icon":1},{"id":"2461985842","title":"BUZZ-实验性抗癌药物在正在进行的试验中显示出前景，Bio-Path 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2461985842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461985842?lang=zh_cn&edition=full","pubTime":"2024-08-21 19:50","pubTimestamp":1724241046,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月21日 - ** Bio-Path控股公司  股价盘前上涨12.8%至1.67美元** 药物开发商称，在一项正在进行的针对一种血癌的中期试验中，使用其实验性药物prexigebersen的联合疗法延长了治疗的持久性** 该公司还表示，在一项正在进行的早期研究中，其另一种癌症候选药物 BP1001-A 在首例服用较高剂量药物的患者身上出现了肿瘤消退现象** 截至上一交易日收盘，该公司股价年累计下跌 84","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BPTH","BK4139"],"gpt_icon":0},{"id":"2461882112","title":"Bio-Path Holdings, Inc.盘中异动 下午盘股价大跌5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461882112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461882112?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:24","pubTimestamp":1724174646,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时24分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫5.33%。截至发稿，该股报1.42美元/股，成交量1.0552万股，换手率0.41%，振幅6.00%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821012407971995a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821012407971995a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2459210608","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速拉升5.37%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210608","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210608?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:00","pubTimestamp":1723816802,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时00分，Bio-Path Holdings, Inc.股票出现异动，股价急速上涨5.37%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3813.84%、1449.13%、162.10%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.、Cingulate Inc.，振幅分别为100.53%、36.81%、35.42%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220002959ef26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220002959ef26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2459236193","title":"Bio Path 控股公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459236193","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459236193?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:29","pubTimestamp":1723771751,"startTime":"0","endTime":"0","summary":"   * Bio Path Holdings Inc   报告，截至6月底的季度调整后每股亏损1.16美元，高于去年同期的每股收益10.60美元。分析师对该季度的唯一预测是每股亏损 1.54 美元。* Bio Path 控股公司本季度报告的每股收益为亏损 1.16 美元。* 该公司当季亏损 187 万美元。* Bio Path Holdings Inc 本季度股价下跌了 24.5%，今年迄今为止下跌了 83.7%。8月16日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 25.2%。华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bio Path 控股公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2459189852","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘急速上涨8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189852","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189852?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:50","pubTimestamp":1723564231,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时50分，Bio-Path Holdings, Inc.股票出现波动，股价大幅拉升8.40%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为134.48%、127.54%、32.93%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为68.92%、40.95%、39.71%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235031af974425&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235031af974425&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":-0.0991},{"period":"1month","weight":0.1171},{"period":"3month","weight":-0.3196},{"period":"6month","weight":-0.6475},{"period":"1year","weight":-0.9221},{"period":"ytd","weight":-0.8949}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.053526},{"month":6,"riseRate":0.545455,"avgChangeRate":0.01417},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.105842},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.169267},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.091013},{"month":10,"riseRate":0.545455,"avgChangeRate":0.085712},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.09554},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况